- Key message that will be delivered to the end consumers
-
Bifidobacterium is really needed to
a baby?
-
The healthy babies who eat breast
milk relieve yellow nature almost without constipation or diarrhea. When it
comes to the intestines of these babies, more than 90 % of bacterium in
intestines is Bifidobacterium.
Bifidobacterium inhibits harmful
bacteria and helps the multiplication of beneficial bacteria in intestines, so
it makes the intestine healthier.
After
weaning diet, more various bacteria live in the intestine and among these
bacteria, there are many bacteria that make rottenness matters. In particular,
as a person ages, a bacterium called "Clostridium welchi
(Clostridium
perfringens)",
a rottenness bacteria, increases in the intestine.
-
Therefore, if a baby
continues to take Bifidobacterium and lactic acid bacteria to increase their numbers in the
intestine, the multiplication of harmful bacteria is inhibited to naturally
keep the intestine health of a baby.
Product Description
-
This is a bifidus
nutrient and intestinal regulation product for Baby, which was developed by the
research team of Professor Ji, Geun Eog at the Food and Nutrition Department of
Seoul National University by using the Bifidobacterium sp.
(BGN4, BORI), Lactobacillus acidophilus and Enterococcus
faecium
isolated from a health Korean baby. In
addition, this product consist of B-complex vitamins such as Vitamin B1, Vitamin B, Vitamin B6,
Vitamin B12,as
well.
Specification
Competitive
1.High adhesion ability to intestinal cells
BIFIDO
R&D Research Center has compared the adhesion ability of many Bifidobacteria
in the intestinal tract. The experimental results shown that the adhesion
ability of BIFIDO patented BGN4 is much higher than other Bifidobacteria
strains. After taking 2 billions BGN4 a day for ten days, the total number of
Bifidobacteria
in the intestine has increased 3-10 times.
Microscopically Bifidobacterium bifidum BGN4 adheres to the gut
2.Safety at the whole geome sequence level
The
whole genome map
of Bifidobacterium bifidum BGN4
and
Bifidobacterium longum BORI
has
been
published in the scientific literatures
by BIFIDO R&D Research Center.
Through whole genome
sequence analysis, safety
has been recognized by FDA at the gene level.
3.
Functions——multiple benefits have been demonstrated
through various studies
4. One-stop industrialization platform based on microbiome research
From the selection of probiotics and
pharmabiotics candidates to the finished products, we have our own R&D and
industrialization platform. We are now expanding our pipelines for other
immune-related disease, including Rheumatoid Arthritis (RA).
5. Global advanced production technology
Our factory